BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/23/2026 8:21:11 AM | Browse: 25 | Download: 190
 |
Received |
|
2025-11-03 09:17 |
|
Peer-Review Started |
|
2025-11-03 09:17 |
|
First Decision by Editorial Office Director |
|
2025-11-14 06:59 |
|
Return for Revision |
|
2025-11-14 06:59 |
|
Revised |
|
2025-11-17 10:13 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-24 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-24 06:30 |
|
Articles in Press |
|
2026-02-24 06:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-03-12 00:37 |
|
Publish the Manuscript Online |
|
2026-03-23 08:21 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Aisha Jamil, Ghulam Sughra, Ghazala Dawood Abbasi, Soukaina Adane, Monica Punshi, Mobashara Ghulam Muhammad, Marium Nausherwan, Yamina Ishtiaq and Muhammad Dawood Hazoor |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Muhammad Dawood Hazoor, MD, Department of Internal Medicine, International University of Kyrgyzstan, ISM IUK Eastern Campus, Bishkek, Kyrgyzstan, 6 Seven April Street, Bishkek 750065, Kyrgyzstan. sidhudawood@gmail.com |
| Key Words |
Endometrial cancer; Atypical hyperplasia; Fertility-sparing management; Progestin therapy; Biomarkers; Ki-67; Human epididymis protein 4; Molecular classification; Reproductive outcomes; Oncologic safety |
| Core Tip |
This multicenter retrospective study of 234 women with atypical hyperplasia or early-stage endometrial cancer demonstrates fertility-sparing management’s efficacy, with 79.9% complete response, 25.1% recurrence, and 50.4% live birth rate. Innovatively, biomarkers (Ki-67 > 20%, human epididymis protein 4 > 50 pmol/L) independently predict recurrence (hazard ratios = 3.12 and 2.78), while molecular classification (e.g., no specific molecular profile favorable) refines patient selection, advocating multidisciplinary approaches for optimized oncologic and reproductive outcomes. |
| Publish Date |
2026-03-23 08:21 |
| Citation |
Jamil A, Sughra G, Abbasi GD, Adane S, Punshi M, Muhammad MG, Nausherwan M, Ishtiaq Y, Hazoor MD. Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease. World J Clin Oncol 2026; 17(3): 116062 |
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i3/116062.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i3.116062 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
